Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Articles

Meticulous system configuration can prevent machines from taking over.

Technology Fights Back

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

An examination of the current and projected market for biosimilars, development costs for biosimilars compared with small-molecule generic drug, and partnerships in biosimilars.

Market Strengths and Weaknesses in Biosimilars

MedImmune, the global biologics arm of AstraZeneca, announced that it is restructuring its infectious disease and vaccines R&D and operations. This will result in the closure of MedImmune's sites in Mountain View and Santa Clara, California.

AstraZeneca Restructures Vaccines R&D and Operations

Amy Ritter was Scientific Editor, BioPharm International.

Sandoz announced it has completed the acquisition of Fougera Pharmaceuticals, a maker of generic dermatology products, for $1.5 billion.

Sandoz Completes Acquisition of Generic Dermatology Company Fougera for $1.5 Billion

GSK Extends Deadline for Tender Offer to Acquire Human Genome Services; Sartorius Opens New Filter, Aseptic-Bag Production Facility in Puerto Rico; and More.

Week of July 2, 2012: GSK Extends Deadline for Tender Offer to Acquire Human Genome Services; Sartorius Opens New Filter, Aseptic-Bag Production Facility in Puerto Rico; and More

Holistic open learning networks offer a new drug R&D model for improving research outcomes.

A New R&D Paradigm

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

Industry experts share their insight on solid-dosage and sterile manufacturing.

35th Anniversary Special: Breakthroughs and Emerging Technologies in Manufacturing

Companies roll out expansions in manufacturing high-potency APIs and finished products.

High-Potency Manufacturing Remains Strong

Developments in hot-melt extrusion using twin-screw extruders to make solid-dosage drug forms.

Hot-Melt Developments

PharmTech's monthly newsletter, Equipment and Processing Report, reviews the Editor's Picks for the June 2012 edition from EMD Millipore and Meissner Filtration Products.